Cargando…
Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia
BACKGROUND: Cachexia is a multifactorial metabolic syndrome with high morbidity and mortality in patients with advanced cancer. The diagnosis of cancer cachexia depends on objective measures of clinical symptoms and a history of weight loss, which lag behind disease progression and have limited util...
Autores principales: | Yang, Quan‐Jun, Zhao, Jiang‐Rong, Hao, Juan, Li, Bin, Huo, Yan, Han, Yong‐Long, Wan, Li‐Li, Li, Jie, Huang, Jinlu, Lu, Jin, Yang, Gen‐Jin, Guo, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803608/ https://www.ncbi.nlm.nih.gov/pubmed/29152916 http://dx.doi.org/10.1002/jcsm.12246 |
Ejemplares similares
-
Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017) -
Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis
por: TANG, YING-MEI, et al.
Publicado: (2015) -
Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy
por: Shao, Mingmei, et al.
Publicado: (2020) -
Metabolomics and its Applications in Cancer Cachexia
por: Cui, Pengfei, et al.
Publicado: (2022) -
Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum
por: Gao, Xianfu, et al.
Publicado: (2012)